Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | Director | Nov 9, 2020 | Sep 8, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 8, 2026, Opus Genetics, Inc.: 784,314 shares vested or acquired by exercising options. 1 filing: 1
- Apr 20, 2026, Opus Genetics, Inc.: 24,367 shares granted. 1 filing: 1
- Jan 6, 2026, Opus Genetics, Inc.: 67,000 shares granted. 1 filing: 1
- Dec 31, 2025, Opus Genetics, Inc.: 33,000 shares granted. 1 filing: 1
- Dec 29, 2025, Opus Genetics, Inc.: bought 164,000 shares for $324K (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.